Web Desk: Pakistan is set to introduce a new digital medicine verification system on November 24 as part of a nationwide effort to curb counterfeit drugs and strengthen pharmaceutical safety.
Prime Minister Shehbaz Sharif is expected to inaugurate the “Mehfooz Dawa” (Safe Medicine) mobile application at a ceremony in Islamabad on Tuesday, according to sources familiar with the initiative.
The application will allow consumers to verify the authenticity of medicines by scanning a unique two-dimensional (2D) barcode printed on pharmaceutical packaging.
Under the new system, patients and consumers will be able to check medicines themselves rather than relying solely on retailers or distributors.
By scanning the 2D barcode through the Mehfooz Dawa application, users will be able to access information about a medicine and verify its authenticity.
Sources said the application would also provide details about a medicine’s expiry date, intended use and price, helping consumers make more informed decisions before purchasing or using pharmaceutical products.
The initiative aims to reduce the circulation of counterfeit and potentially unsafe medicines while improving transparency across Pakistan’s pharmaceutical supply chain.
The application’s launch follows the introduction of mandatory pharmaceutical tracking requirements designed to monitor medicines throughout the supply chain.
According to sources, authorities have required every medicine to carry a unique 2D data barcode and serial number since October 9.
The identification system is intended to make individual pharmaceutical products traceable and help authorities distinguish legitimate medicines from counterfeit products.
